FDA Approved: ZIPRASIDONE MESYLATE — Original Application (Fosun Pharma USA Inc.)

View source ↗

Summary

FDA approved the original application for ziprasidone mesylate (generic) to treat schizophrenia and bipolar I disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Ziprasidone mesylate (Ziprasidone mesylate)

Snippet

ORIG AP for ZIPRASIDONE MESYLATE (ZIPRASIDONE MESYLATE)